Companies Dominating the Bioengineered Protein Drug Landscape
- Abbott Services
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Johnson & Johnson Services, Inc.
- Amgen Inc.
- Bayer AG
- Dr. Reddy’s Laboratories Ltd.
- Biocon Limited
- Eli Lilly and Company
- Sanofi S.A
- GlaxoSmithKline plc
- F. Hoffmann-La Roche Ltd
Browse Key Market Insights with Data Illustration:
In the News
-
Abbott acquired St. Jude Medical, Inc., a medical device firm. The acquisition is expected to help Abbott Laboratories expand its market share in medical devices and improve its bio-engineered stent product range worldwide.
-
GlaxoSmithKline plc announced the retrospective study results on clinical trial diversity. The study included 495 GSK and ViiV clinical trials and was based on US participants.
